openPR Logo
Press release

Virtual Clinical Trials Market Size, Share, Growth, Trends And Forecast 2023-2032

Virtual Clinical Trials Market Report

Virtual Clinical Trials Market Report

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Virtual Clinical Trials Global Market Report 2023 identifies the increasing investments by the government and pharmaceutical companies in new vaccines and drug development as the major driver for the virtual clinical trials market's growth in the forecast period. The R&D divisions in the medical industry are increasingly utilizing virtual clinical trial solutions and services to increase quality assurance and clinical data management of drugs and their products.

The global virtual clinical trials market size will grow from $9.68 billion in 2022 to $10.49 billion in 2023 at a compound annual growth rate (CAGR) of 8.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global virtual clinical trials industry is expected to grow to $14.82 billion in 2027 at a CAGR of 9.0%.

Download Free Sample Of Virtual Clinical Trials Market Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=6362&type=smp

Major competitors in the virtual clinical trials market are Parexel International, IQVIA, Covance, PRA Health Sciences, LEO Innovation Lab.

A key trend in the virtual clinical trials market includes technology advancement. Major companies operating in the virtual clinical trials market are focused on providing technologically-advanced solutions to meet fast-growing industry demands and strengthen their market position. These companies are implementing new generation virtual clinical technologies into their services, such as wearable technologies, mHealth, blockchain, cloud computing, EMR integration, actionable data, threshold monitoring, AI, SFTP, ETL services, and others. For instance, In April 2022, Unlearn.AI, a US-based startup, will launch a new digital twin RCTs technology for clinical trials that enables smaller control groups while maintaining power and generating evidence suitable for supporting regulatory decisions using AI and historical data.

Read More On The Global Virtual Clinical Trials Market Report Here:
https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

The virtual clinical trials market is segmented -
•By Design: Observational Trials, Interventional Trials, Expanded Access Trials
•By Phases: Phase I, Phase II, Phase III, Phase IV
•By Indication: CNS, Autoimmune/Inflammation, Cardiovascular Disease, Metabolic/Endocrinology, Infectious Disease, Oncology, Genitourinary, Ophthalmology, Other Indications
•By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the virtual clinical trials market.

The Business Research Company's "Global Virtual Clinical Trials Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Virtual Clinical Trials Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6362

The Table Of Content For The Virtual Clinical Trials Market Include:
1. Executive Summary
2. Virtual Clinical Trials Market Characteristics
3. Virtual Clinical Trials Market Trends And Strategies
4. Virtual Clinical Trials - Macro Economic Scenario
5. Virtual Clinical Trials Market Size And Growth
……
26. Africa Virtual Clinical Trials Market
27. Virtual Clinical Trials Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Virtual Clinical Trials Market
29. Virtual Clinical Trials Market Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Virtual Clinical Trials Market Size, Share, Growth, Trends And Forecast 2023-2032 here

News-ID: 3195832 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Trials

Clinical Trials Management System Market Trends: How Decentralized Clinical Tria …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical Device Firms, CROs)- Market Outlook And Industry Analysis 2031" The global Clinical Trials Management System market is estimated to reach
Brazil Clinical Trials Market ANVISA Brazil Guidelines Brazil Clinical Trials Re …
Brazil Cancer Drugs Clinical Trials Insight 2024 Report Offering: • Brazil Clinical Trials Market Opportunity 2024 and 2030 (In US$ Billion) • Clinical Trials Regulatory Framework In Brazil • Total Number of Cancer Drugs In Clinical Trials In Brazil • Total Number Of Cancer Drugs Approved In Brazil • 400 Pages Clinical Trials Insight On All Cancer Drugs In Clinical Trials By Company, Indication and Phase • 80 Pages Clinical Insight On All Cancer Drugs Approved in Market By Company and Indication • Insight
Clinical Trials Management System Market Clinical Trials Management System Marke …
InsightAce Analytic announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical Device Firms, CROs)- Market Outlook And Industry Analysis 2031. The global Clinical Trials Management System market is estimated to reach over USD
Revolutionizing Clinical Trials: The Evolution of eCOA, eSource, and the Clinica …
The global eCOA, eSource & clinical trials market is valued at US$ 48 billion in 2023 and is expected to reach a market size of US$ 104 billion by the end of 2033, expanding rapidly at a CAGR of 8% over the next ten years. Worldwide demand for eCOA (electronic clinical outcome assessment) solutions is predicted to rise at a CAGR of 8.2% over the forecast period. In the dynamic landscape
Virtual Clinical Trials Market - Bridging the Gap: Virtual Clinical Trials Revol …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Virtual Clinical Trials Market. Virtual Clinical Trials Market: https://www.growthplusreports.com/report/virtual-clinical-trials-market/9106 The Virtual Clinical Trials Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the
Clinical Trials Market: Coronavirus Pandemic Pushes Sponsors, Patients to Adopt …
Clinical trials Market: Introduction According to the report, the global clinical trials market was valued over US$ 46.7 Bn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030. High prevalence and increase in incidence rate of chronic diseases, and rise in R&D activities in biotechnology & pharmaceuticals industries are anticipated to drive the global clinical trials market from 2020 to 2030. North America is projected to